Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 3/20 | 0.57 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.57 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.57 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.51 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.46 |
| ▸ | HTR3B | O95264 | 1/20 | 0.46 |
| ▸ | HTR3A | P46098 | 1/20 | 0.46 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.46 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30311886 | 1.00 | CHRM3 (0.57) | CHRM3CHRM2CHRM1CHRNA7HTR3E | |
| SCHEMBL2996277 | 1.00 | CHRM3 (0.57) | CHRM3CHRM2CHRM1CHRNA7HTR3E | |
| SCHEMBL8943980 | 1.00 | CHRM3 (0.57) | CHRM3CHRM2CHRM1CHRNA7HTR3E | |
| SCHEMBL29013256 | 1.00 | CHRM3 (0.57) | CHRM3CHRM2CHRM1CHRNA7HTR3E | |
| SCHEMBL6846711 | 1.00 | CHRM3 (0.57) | CHRM3CHRM2CHRM1CHRNA7HTR3E | |
| SCHEMBL10747525 | 0.76 | CHRM2 (0.57) | CHRM3CHRM2CHRM1CHRNA7HTR3A | |
| SCHEMBL7279780 | 0.74 | CHRNA7 (0.45) | CHRM3CHRM2CHRM1CHRNA7HTR3E | |
| SCHEMBL27261538 | 0.73 | HTT (0.51) | — | |
| SCHEMBL9269083 | 0.73 | KMT2A (0.62) | — | |
| SCHEMBL31297148 | 0.73 | CRBN (0.49) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115850120-A | Preparation method of alcohol alpha-carbon hydrogen bond alkylated compound | 浙江工业大学 | 2023-03-28 | — | — | CN | claimed |
| US-5576434-A | (1-azabicyclo[2.2.2]oct-3-yl) (1,2,3,4-tetrahydronaphthalen-1-ylmethyl)amine and n-(1-azabicyclo[2.2.2]oc | HELSINN HEALTHCARE SA (CH) | 1996-11-19 | — | — | US | claimed |
| CN-115850120-A | Preparation method of alcohol alpha-carbon hydrogen bond alkylated compound | 浙江工业大学 | 2023-03-28 | — | — | CN | disclosed |
| US-20130079521-A1 | NOVEL PALONOSETRON SALTS AND PROCESSES FOR PREPARATION AND PURIFICATION THEREOF | CHEMAGIS LTD. (IL) | 2013-03-28 | — | — | US | disclosed |
| US-8334388-B2 | Palonosetron salts and processes for preparation and purification thereof | CHEMAGIS LTD. (IL) | 2012-12-18 | — | — | US | disclosed |
| US-8334388-B2 | Palonosetron salts and processes for preparation and purification thereof | CHEMAGIS LTD. (IL) | 2012-12-18 | — | — | US | disclosed |
| US-20100174080-A1 | NOVEL PALONOSETRON SALTS AND PROCESSES FOR PREPARATION AND PURIFICATION THEREOF | CHEMAGIS LTD. (IL) | 2010-07-08 | — | — | US | disclosed |
| US-20100174080-A1 | NOVEL PALONOSETRON SALTS AND PROCESSES FOR PREPARATION AND PURIFICATION THEREOF | CHEMAGIS LTD. (IL) | 2010-07-08 | — | — | US | disclosed |
| US-5576434-A | (1-azabicyclo[2.2.2]oct-3-yl) (1,2,3,4-tetrahydronaphthalen-1-ylmethyl)amine and n-(1-azabicyclo[2.2.2]oc | HELSINN HEALTHCARE SA (CH) | 1996-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100174080-A1 | NOVEL PALONOSETRON SALTS AND PROCESSES FOR PREPARATION AND PURIFICATION THEREOF | HTR3C, HTR3A, CYP3A43 | CHRM3 1404/4885CHRM2 3175/4885CHRM1 3214/4885 |
| US-20130079521-A1 | NOVEL PALONOSETRON SALTS AND PROCESSES FOR PREPARATION AND PURIFICATION THEREOF | HTR3C, HTR3A, CYP3A43 | CHRM3 1259/4885CHRM2 2924/4885CHRM1 2926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.